Navigation Links
Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
Date:2/18/2009

LYON, France, February 18 /PRNewswire-FirstCall/ --

- Global Clinical Study Program Across Dengue Endemic Regions in Latin America and Asia

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced today that its investigational tetravalent dengue vaccine is entering into a pediatric clinical study in Thailand to assess the efficacy of the vaccine in protecting children against dengue, the most widespread tropical disease after malaria. Sanofi Pasteur's tetravalent dengue vaccine candidate is the first to reach this stage of clinical development.

Sanofi Pasteur is collaborating with Mahidol University of Thailand, the Ministry of Public Health, and the Pediatric Dengue Vaccine Initiative (PDVI) to conduct this efficacy study in the province of Ratchaburi.

"Large scale pediatric studies are instrumental for the development of a safe and efficacious dengue vaccine to protect against a disease that primarily affects children," said Dr. Pratap Singhasivanon, Dean of the Faculty of Tropical Medicine, Mahidol University. "We are happy to contribute to an important milestone with the actual start of an efficacy study in Ratchaburi."

The Sanofi Pasteur clinical study program follows guidelines from the Initiative for Vaccine Research (IVR) led by the World Health Organization (WHO), which fosters the global efforts towards dengue vaccine development.

"WHO is committed to the availability of a dengue vaccine that will ultimately benefit children in endemic countries," said Dr. Joachim Hombach, Coordinator Implementation Research for IVR, WHO.

About Sanofi Pasteur dengue vaccine global clinical study program

Sanofi Pasteur started the development of a dengue vaccine in the 90's. Clinical studies with the most advanced tetravalent candidate vaccine started in the 2000's. In a study in the U
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Demand for VScan Dengue Fever Test Kits Increases
10. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
11. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Re...elopmentofantithromboticaptamerswithactivecontrola...willbepresentingatthePiperJaffray21stAnnualHealthC...Dr.Mazzo,spresentationwillbegivenat1:10pm(EST)onTu...y,spipelinewithemphasisontheleaddevelopmentprogram...
(Date:11/25/2009)... ,, UNIONCITY,Calif.,Nov.25/PRNewswire-First...companymanufacturingpoint-of-carebloodanalysissyst...efexecutiveofficer,willpresentatthe21stAnnualPiper...009at2:00p.m.ET.TheconferencewillbeheldattheNewYor..., Abaxisdevelops,manufacturesandmarketsportablebl...
(Date:11/25/2009)... ,, CHAPELHILL,N.C.,Nov.25/PRNewswire/--Cemp...Fernandes,presidentandchiefexecutiveofficer,willpr...ceat8:50a.m.EST,December1,2009,atTheNewYorkPalaceH...wofthecompany,stwoleadingantibioticclinicalprogram...MRSA. ,, AboutCempraPharmaceuticals ,, Fou...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 1Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 2Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 3Healthcare Staffing Company Medical Solutions Named Among 26quot 3B2009 Best Places to Work in Omaha 26quot 3B 50145 4Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 50143 1Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson 50143 2Latin America must cut blood pressure to thrive 50141 1Latin America must cut blood pressure to thrive 50141 2Latin America must cut blood pressure to thrive 50141 3
...ovement in disease activity observed through 2.5 y...continuation trial -, - No observed increase in ra...alignancies and infections over 2.5 years of Lymph...n Genome Sciences,Inc. (Nasdaq: HGSI ) today anno... demonstrating that LymphoStat-B(R) (belimumab) ac...
...expanded routine screening, WASHINGTON, Nov. 8 T...ommission for Public Health and the North,Carolina...ws to include the,Centers for Disease Control and ...ning a part of routine medical care. Now in North ...ral consent and pre-test counseling is,no longer r...
Other Medicine Technology:Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 8Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing 2
(Date:11/25/2009)...may lead to new drugs for people, researchers say ...-- Sphingadienes, natural lipid molecules found in...for colon cancer, California researchers have foun...dy authors pointed out that they could help explai...n cancer. , In the study, Dr. Julie Saba, senio...
(Date:11/25/2009)...ochondrial function plays in insulin production ,... Mitochondrial damage causes people with type 2 di...that could lead to new treatments, U.S. researcher...ar activity. , The researchers found that when ... respond to circulating insulin, it triggers a "mo...
(Date:11/25/2009)...ing support for recent enforcement actions against...sociation of Chain Drug Stores (NACDS) submitted a... The letter expresses the Association’s con... foreign, that are engaged in a pattern of illegal... of prescription medications. , ...
(Date:11/25/2009).../PRNewswire-FirstCall/-- TheProvidenceServiceCorp...Caresubsidiary,thenation,slargestcoordinatorofnon-...ticeofawardfromtheStateofFloridaCommissionfortheTr...gencytransportationservicestobothMiami-DadeandVolu...nrevenueovertheinitial18monthterm,issubjecttofinal...
(Date:11/25/2009)...ewswire-USNewswire/--/EINNews/EINNews,anonlinelead...oducesitsnewesthealth-relatedpublicationforindustr...n1.einnews.com ). ,, H1N1NewsTodaygathersthelat...,newsoutletsandresearchcenterstheworldover,searchi...baloutbreakwithreportsfromeverystateandeverycountr...
Breaking Medicine News(10 mins):Health News:Natural Soy Component May Help Treat Colon Cancer 2Health News:NACDS Supports FDA Enforcement Against Rogue Internet Pharmacy Websites 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2
...r Health,System of Warrenton, Virginia announces a... service professionals are all too familiar with,t...ively presented product,samples in the hopes of wi...ient care to the selection of food. He,arranged fo...
...for St. Margaret,s Daughters, Home, NEW ORLEANS, ...ughters, Home in New Orleans will be reunited in a...ey evacuated in the wake,of Hurricane Katrina. Th...s was evacuated safely before the storm, federal d...
...ct and treat Alzheimers Disease (AD) in its earlie...d degrees of cognitive impairment, thanks to new d...oup of researchers., Published in Lancet Neurology...Medicine.,Feldman, who directs the Clinic for Alzh...
...s General Assembly Tomorrow, September ...ith 35,000 people dying,of hunger every day and go...ent to halve hunger by 2015, the international dev...l Assembly,Meetings. "The UN is failing on its co...
...in more powerful and sneaky ways than have been re...K that is closely related to a common cancer-causi... an unexpected manner. JAK disrupts the activity o...chester Medical Center made the finding, published...
...tip Formulary announces,the immediate availability...ervice designed for healthcare providers. The Fing...of the managed care lives in the U.S. and Puerto,R...mple- to-use, unique, handheld application that is...
Other Medicine News:Health News:Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judge's Pen as Vendors Vie for Approval 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 3Health News:New way to diagnose Alzheimer's disease promises earlier treatment 2Health News:HungerFREE Campaign Tells UN: 'Put food on the table' 2Health News:If you think cancer genes are simple, you don't know JAK 2Health News:If you think cancer genes are simple, you don't know JAK 3Health News:If you think cancer genes are simple, you don't know JAK 4Health News:If you think cancer genes are simple, you don't know JAK 5Health News:Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDA's 2
5107 Bariatric Physician's Scale®
...100 provides a new screening, diagnostic, treatmen...n the medical management of sleep-related breathin...ill the unmet need for an ambulatory, reliable, pa...accessible to the great number of OSA sufferers, a...
...rmone (PTH) is synthesized by the parathyroid glan...racellular calcium concentrations. PTH prevents hy...sing calcium excretion by the kidney. Following re...degraded into 4 fragments: N-terminal (residues 1-...
...osterone (DHEA) is produced in the adrenal cortex ...serves as a precursor in testosterone and estrogen...ivity, estimated at ~10% that of testosterone [1]....n adult women, DHEA is an important androgen as ci...
Medicine Products: